Intezyne Technologies, Inc.
- UEI
- JBLXMZV2JU83
- CAGE
- 458E9
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Epothilone d formulated in polymer micelle nanoparticles | National Cancer Institute | $944,762 | |
| Micellar daunorubicin for the treatment of bone cancer | National Institutes of Health | $156,868 | |
| Targeted polymer micelles for treatment of metastatic melanoma | National Institutes of Health | $139,587 | |
| Other functions - r & d biomedical (basic research) | National Cancer Institute | $187,222 |
Quick answers
What is Intezyne Technologies, Inc.'s UEI?
Intezyne Technologies, Inc.'s Unique Entity ID (UEI) in SAM.gov is JBLXMZV2JU83.
What is Intezyne Technologies, Inc.'s CAGE code?
Intezyne Technologies, Inc.'s CAGE code is 458E9.
What is Intezyne Technologies, Inc.'s primary NAICS code?
Intezyne Technologies, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Intezyne Technologies, Inc. registered in SAM.gov?
Intezyne Technologies, Inc.'s SAM.gov registration expired on July 30, 2019.
What is Intezyne Technologies, Inc.'s most recent federal award?
Intezyne Technologies, Inc.'s most recent federal contract award is Epothilone d formulated in polymer micelle nanoparticles (HHSN261201400018C), from National Cancer Institute, on September 18, 2014.
On GovTribe
See Intezyne Technologies, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors